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Our understanding of the genetic etiology of complex disorders is still elusive. According to the common-variant/
common-disease hypothesis, frequent functional polymorphisms are the best candidates for disease-susceptibility
alleles. Implicitly, we also assume that disease-susceptibility alleles are preferentially transmitted from parents to
the affected offspring and that this effect can be captured by the transmission/disequilibrium test (TDT). However,
our study of genetic predisposition to childhood acute lymphoblastic leukemia suggests that a focus on the patient’s
genotype might, in certain instances, be misleading. Our results indicate that, at least at some loci, parental genetics
might be of primary importance in predicting the risk of cancer in this pediatric model of a complex disease.
Consequently, in addition to TDT, other complementary strategies will need to be simultaneously applied to dissect
genetic predisposition to complex disorders.
The great progress made toward an understanding of
Mendelian inheritance in humans has, to a large extent,
been due to the characterization of molecular origins of
monogenic diseases. Mutations underlying these con-
ditions, dominant or recessive, are typically rare and
usually highly penetrant. In contrast, our understanding
of the genetic etiology of complex disorders, such as
diabetes, cancer, cardiovascular diseases, or asthma, is
limited. According to the common-disease/common-
variant hypothesis (Cargill et al. 1999; Chakravarti
1999; Reich and Lander 2001), frequent functional poly-
morphisms, rather then rare mutations, appear to be the
best candidates for disease-susceptibility alleles. This is
consistent with the role of APOE e4 allele in Alzheimer
disease (Corder et al. 1993), factor VLeiden in deep venous
thrombosis (Bertina et al. 1994), or PPARg Pro12Ala
polymorphism in type II diabetes (Altshuler et al. 2000),
to name a few examples. It is also generally assumed
that the environmental context influences the phenotypic
expression of these genetic variants. The resultant dis-
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ease would thus originate through the collective contri-
bution of different genes, environmental factors, and
their interactions. Studies of linkage and association be-
tween disease and marker alleles are intended to identify
loci affecting the disease. The transmission/disequilib-
rium test (TDT) (Spielman et al. 1993) is considered to
be a powerful test in the mapping of complex diseases
(Risch and Merikangas 1996). However, additional
strategies should be considered when one is tracing the
genetic etiology of complex diseases (Bell and Taylor
1997; Long et al. 1997; Muller-Myhsok and Abel 1997;
Scott et al. 1997; Haines and Pericak-Vance 1998;
Pericak-Vance 1998; Speer 1998; Terwilliger and Goring
2000).
It is plausible that, in the genetic association studies
of common genetic diseases, one should consider, in ad-
dition to the patients’ genetics, the parental genetic con-
text. For example, given the correlation between birth
weight, influenced by the mother’s genetics, and suscep-
tibility to a number of common diseases occurring dur-
ing adult life (Ferguson et al. 2000; Godfrey and Bark-
er 2001; Morley and Dwyer 2001), one can hypothe-
size that the mother’s genotype at the particular loci
contributes to and even predetermines the offspring’s
health. In the case of cancer, maternal exposure dur-
ing pregnancy may influence disease risk during child-
hood (Infante-Rivard et al. 1999), as well as during
adulthood (Ekbom 1998), especially given that, com-
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Figure 1 Types of study designs and their outcomes, depending
on the underlying genetics. A, Situation expected when TDT is used
and when patient’s genetics counts. Parents are like control individuals,
and there is a bias in the transmission of disease-susceptibility alleles
(half-blackened symbols) to the affected children. This results in higher
frequency of at-risk or protective alleles in patients, which also is
apparent in a comparison with control individuals. B, Frequency of
disease-susceptibility alleles. The frequency is higher in patients than
in control individuals; however, a random transmission of parental
chromosomes to the affected children results in a negative TDT. Case-
control analysis reveals differences between patients and control in-
dividuals, simply reflecting what already had been present in an earlier
generation, seen as differences between control individuals and parents
(either only the mother or only the father or both). Plus () and minus
() signs denote significant and nonsignificant TDT results, respec-
tively, whereas equality (p) and inequality ( ) signs refer to suscep-
tibility-allele frequency in cases compared with that in control indi-
viduals. The study outcome depicted in panel A corresponds to the
results obtained with GSTP1*C, and that in panel B corresponds to
the results obtained with CYP2E1*5, as reported in table 1.
pared to adults, the fetus appears to be more vulnerable
to genetic damage by carcinogens (Perera 1997). Fetal
effects resulting from maternal exposure might be af-
fected by the efficiency of the mother’s detoxification
systems and, thus, by her genotype. The consequences
can remain “imprinted,” as acquired susceptibility, even
if a child has not inherited the disease-susceptibility al-
lele itself. By extending this concept to a prezygotic stage,
at the level of gametes, one could hypothesize that the
paternal genetics may play a similar role (Infante-Rivard
and Sinnett 1999). In males, for example, there are a
greater number of cell divisions during spermatogenesis
than during oogenesis. This leads to a relative excess of
mutations resulting naturally from DNA replication er-
rors, which explains the higher risk of mutations that is
associated with increased paternal age (Crow 2000). The
number of mutations is increased because of carcino-
genic exposure. This effect might be enhanced further
by the presence of genetic variants in components of
DNA repair that control both replication errors and the
level of “environmental” DNA damage (Miller et al.
2001).
We hypothesized, therefore, that, in certain in-
stances—and especially in the presence of exposure and
genetic polymorphisms—susceptibility to a disease could
be a consequence of a patient’s mother’s and/or father’s
genotypes, rather than of the patient’s own combination
of alleles; in other words, if the parental genotypes,
rather than the offspring’s genotypes, were responsible
for genetic susceptibility to a disease, analysis such as
TDT (Spielman et al. 1993) would fail to detect the
disease-susceptibility allele(s). Figure 1 illustrates the
possible outcomes of TDT and case-control analysis,
given that either the patient’s or the parents’ genotypes
are associated with susceptibility to a disease. In TDT,
a significant deviation from random transmission of al-
leles from heterozygous parents to their offspring can be
interpreted as association and linkage (fig. 1A). At the
same time, an appropriate case-control study with suf-
ficient power would detect an association, because the
frequency of the tested allele significantly differs between
patients and control individuals. On the other hand, let
us consider a situation in which only the parents’ (either
mother’s or father’s or both) genotypes account for the
child’s susceptibility. The population of parents is then
expected to differ from the control population. Parent-
to-child transmissions could be random, leading to a
negative TDT result (fig. 1B); however, in spite of a
random parent-to-patient transmission, the patients and
control individuals would differ as well. When parents
are themselves enriched in disease-susceptibility alleles,
even if they transmit randomly, their offspring also will
have more disease-susceptibility alleles than are found
in control individuals. If TDT analysis is not includ-
ed, then, when the scenario of figure 1B applies, the
patients’ susceptibility resulting from the case-control
analysis would be erroneously interpreted as a result of
their own genotypes, whereas it reflects only the effect
of the parental genotypes.
Indeed, our study of two genetic loci predisposing to
childhood acute lymphoblastic leukemia (ALL) suggests
that, at certain loci, the parental genotypes, rather than
the genotype of the patient, are the predicting risk factor
in this pediatric model of a complex disease. Conse-
quently, we propose that a number of complementary
mapping strategies will be required, such as the com-
bination of case-control and TDT tests, to dissect genetic
predisposition to complex disorders.
In the analysis of genetic susceptibility to ALL we
Reports 195
Table 1
Case-Control and TDT Analysis
ANALYSISa
NO. (%) OF INDIVIDUALS
Patients vs.
Control Individuals
Mothers vs.
Control Individuals
Fathers vs.
Control Individuals
Patients Controls Mothers Controls Fathers Controls
CYP2E1*5:
Absent 87 (90.6) 292 (97.0) 110 (90.2) 144 (98.0) 92 (88.5) 148 (96.1)
Present 9 (9.4) 9 (3.0) 12 (9.8) 3 (2.0) 12 (11.5) 6 (3.9)
ORcc 3.4 (1.3–8.7) 5.2 (1.4–19.0) 3.2 (1.2–8.9)
Pcc .02 .007 .02
ORTDT 1.0 (.4–2.5)
PTDT 1.0
GSTP1*C:
Absent 77 (92.8) 264 (87.4) 99 (84.6) 129 (86.6) 82 (85.4) 135 (88.2)
Present 6 (7.2) 38 (12.6) 18 (15.4) 20 (13.4) 14 (14.6) 18 (11.8)
ORcc .5 (.2–1.3) 1.2 (.6–2.3) 1.3 (.6–2.7)
Pcc .2 .7 .6
ORTDT .4 (.2–.8)
PTDT .01
NOTE.—Because only patients whose parents’ DNA was available were included here, their number is smaller
than that in our previous reports of case-control analysis, in which the following results were obtained: (i)
(range 1.2–6.5), , ; and (ii) (range 0.4–1.1), ,OR p 2.8 P p .02 n p 174 OR p 0.7 P p .1 n p 278∗ ∗CYP2E1 5 GSTP1 C
(Krajinovic et al. 2002; M. Krajinovic, D. Labuda, and D. Sinnett, unpublished data).
a cc p Case control.
performed both case-control (Krajinovic et al. 1999) and
case-only studies (Infante-Rivard et al. 1999), in a group
of patients with ALL who were of French-Canadian or-
igin and who were treated at the Sainte-Justine Hospital
in Montreal. Several genes encoding carcinogen-metab-
olizing enzymes appeared to play a role in susceptibility
to this disease (Sinnett et al. 2000). The parents of the
participating patients with ALL were also recruited, to
assess the effect of their genetics, in addition to that of
their affected children. Genotyping of patients’ parents
was performed as described elsewhere for patients and
control individuals (Krajinovic et al. 1999, 2002; Sinnett
et al. 2000; M. Krajinovic, D. Labuda, and D. Sinnett,
unpublished data). Genotype-frequency differences be-
tween cases and control individuals were assessed by x2
statistics. The level of significance was calculated by
Fisher’s exact test, and the strength of association was
expressed by the odds ratio (OR) and its 95% CI. The
TDT was run by the TDT/S-TDT program (version 1.1)
(Spielman et al. 1993). Risk (with 95% CI) associated
with transmitted variants was calculated according to
the association measures for matched pairs (Lachin
2000). In table 1, we report the results obtained from
180 case-parents trios, applying both the TDT and the
case-control analysis and using, as cases, either patients
or their parents and the control individuals reported
elsewhere.
The analysis of two genetic loci, those for glutathione
S-transferase P1 (GSTP1 [MIM 134660]) and cyto-
chrome P450 2E1 (CYP2E1 [MIM 124040]), revealed
results corresponding to the scenarios illustrated in fig-
ure 1A and B, respectively. The effect of the GSTP1*C
variant is related to its presence/absence in the affect-
ed individual. The TDT analysis documents a reduced
transmission of this variant, to the patients with ALL,
from their heterozygous parents, implying that
GSTP1*C is possibly protective against ALL. In a case-
control study (table 1; M. Krajinovic, D. Labuda, and
D. Sinnett, unpublished data), a similar association was
suggested. In contrast, the variant CYP2E1*5, which, in
a case-control study, appeared to confer an increased
risk of ALL (Krajinovic et al. 2002), was negative in the
TDT analysis. This indicates that the purported disease-
susceptibility allele CYP2E1*5 is randomly transmitted
from parents to the affected children. If the observed
association is not spurious (see below), it suggests that
the model, assuming that the genetic susceptibility is a
function of patient’s genotype, might not be adequate.
Furthermore, the case-control results are replicated
when the parents are substituted for the cases. Thus, an
increased frequency of the disease-susceptibility allele
among patients appears to reflect its overabundance in
an earlier generation. The variant CYP2E1*5, conferring
elevated transcription levels, has been associated with
higher cancer risk (Watanabe et al. 1994; Shields et al.
1996). This effect includes childhood ALL (Krajinovic
et al. 2002), the risk of which has been found to be
particularly enhanced in relation to an increased alcohol
consumption (Infante-Rivard et al. 2002). Therefore, it
is plausible that the parents’ genetics combined with al-
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cohol intake may increase cancer risk in their offspring.
The risk, originally due to CYP2E1*5, is, however,
transmitted to the future potential patients indepen-
dently of this genetic variant (see fig. 1B).
A major concern in case-control studies is the pos-
sibility of a false-positive association due to nonhom-
ogeneity of the population structure. Indeed, one of the
great advantages of the TDT analysis is that it elimi-
nates the possibility of spurious association due to pop-
ulation heterogeneity (Falk and Rubinstein 1987;
Spielman et al. 1993; Risch and Merikangas 1996; Per-
icak-Vance 1998; Speer 1998). Negative TDT results
observed in the case of the CYP2E1 gene could there-
fore simply indicate such spurious association obtained
from the case-control analysis. There are several rea-
sons to believe that this is not the case. First, both
patients and control individuals originate from the
same French-Canadian population of Quebec, where
no regional clustering of childhood ALL was observed.
Both patients and control individuals are expected to
share, to the same extent, the ancestry among ∼5,000
immigrants who founded “Nouvelle-France” during
the 17th century (Courville 1996). Second, the analy-
sis of our control population by the STRUCTURE pro-
gram (Pritchard et al. 2000) clusters all individuals into
a single population (proportion of individual’s genome
originating in a single population [Q] is 0.994), thus
suggesting population homogeneity and supporting our
inclusion criteria (Krajinovic et al. 1999). The STRUC-
TURE program (Pritchard et al. 2000) was used, with
the assumption that there are three population clus-
ters, on the population of control individuals that were
genotyped at 11 multiallelic and 7 biallelic loci dis-
tributed over the genome (Krajinovic et al. 1999, 2000,
2002; M. Krajinovic, D. Labuda, and D. Sinnett, un-
published data). Third, the case-control results re-
ported in the present study (i.e., those which use only
patients within familial trios) are consistent with those
obtained with a larger cohort of our patients, where
chances of a type I error are smaller (see the general
“Note” to table 1). The effect of GSTP1*C was sug-
gested by case-control analysis, and, in the present
study, this result was reinforced by TDT. Fourth, the
observed associations between CYP2E1*5 and cancer
susceptibility are not limited to childhood ALL as noted
by others (Shields et al. 1996; Hung et al. 1997). The
effect of CYP2E1*5—via parental contribution in the
context of gene-environment interaction, such as that
due to alcohol exposure—is biologically plausible (In-
fante-Rivard et al. 2002). Finally, TDT works only for
cases in which the patient’s genotypes count and thus,
by default, is not suitable to detect the observed effect
that parental genetics has in the present study.
Although the importance of parents’ exposure has of-
ten been studied, the influence that their disease-suscep-
tibility alleles have on the development of diseases in
their offspring has been surprisingly neglected. The re-
sults described in the present study could represent a
new paradigm in our comprehension of the mapping of
complex disorders, since they may be extended to at least
some clinical entities of other disorders, beyond cancer
or childhood diseases. This possibility is suggested by
recent epidemiological studies linking poor intrauterine
growth, due to maternal factors, with health problems
in adult life (Nyirenda and Seckl 1998). Our results also
remind us that computational approaches, despite their
power, may be misleading if they are based on inappro-
priate assumptions (see Terwilliger and Goring 2000).
Instead, relying on a single test that assesses only limited
genetic effect, we propose that, whenever possible, a
wide spectrum of study designs should be considered;
this may also mean, for example, that the analysis of
gene-environment interaction should be included, in ad-
dition to analysis of the immediate effects that genetics
has at the level of the patient and the parents.
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